Based on the above reported in vitro experiments, correlating total β-catenin in HER2+ tumor cells with their invasive potential, we explored the relationship between patient’s follow-up and total β-catenin in their breast tumors. This evidence concerns the gene ERBB2 and breast neoplasm.